Navigation Links
Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
Date:11/28/2007

Company Plans to Initiate Phase III Program in First Half of 2008

LEXINGTON, Mass., Nov. 28 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced positive results from its Phase II octreotide implant trial in patients with acromegaly, a disorder characterized by excessive blood levels of growth hormone (GH) and insulin- like growth factor 1 (IGF-1). The implant utilizes the Company's patented Hydron technology to deliver effective levels of octreotide for six months. Octreotide is a synthetic peptide that mimics the natural hormone somatostatin to block release of GH. In the recently completed six-month trial, the octreotide implant effectively suppressed levels of GH and IGF-1 at rates similar to those seen with current FDA approved injectable formulations of octreotide. In addition, the drug was well tolerated.

"I am extremely pleased to report the successful completion of our octreotide implant trial and we are looking forward to the initiation of our Phase III program in the first half of 2008," stated Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. "The market opportunity for a six-month octreotide implant for the treatment of acromegaly is substantial. The results of the trial demonstrate the potential of our octreotide implant, the only once every six month treatment, to improve the treatment options for people who suffer from this life-long debilitating condition. In addition, based on the successful results of this trial, we are exploring opportunities to expand our octreotide development program to address other indications where injectable formulations of octreotide are currently utilized, including carcinoid tumors."

The trial w
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Submission of New Drug Application
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Workers Ensure Emergency Deliveries are Transporte...ire/ -- Teamster members employed by the Philadelp...work educating the public about the unfair labor c...put Philadelphia,s blood supply at risk. More tha... line yesterday when their issues were ignored by ...
(Date:12/4/2009)...ALT LAKE CITY, Dec. 4 Dy...t has signed a sole-source vendor agreement to pro...mark Physical Therapy with 65 clinics located in T... named the sole-source supplier to Benchmark Physi...ce president of sales and marketing at Dynatronics...
(Date:12/4/2009)... , LAKE FOREST, Ill., Dec. 4 /PRNewswir...ading global specialty pharmaceutical and medicati... its next-generation 50 mL and 100 mL VisIV(TM) co...lutions, and now offers a complete size range (50 ...esponsible VisIV product. The launch of the 50 mL ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 42 500 Cases Completed With the Magnetic Irrigated Catheter 4825 12 500 Cases Completed With the Magnetic Irrigated Catheter 4825 22 500 Cases Completed With the Magnetic Irrigated Catheter 4825 3Cord Blood America Retires 242 53M Obligation 13371 1Cord Blood America Retires 242 53M Obligation 13371 2Cord Blood America Retires 242 53M Obligation 13371 3SK Life Sciences has Licensed Pristima 13368 1SK Life Sciences has Licensed Pristima 13368 2
(Date:12/4/2009)...Dec. 4 Thousands of KPMG LLP emplo...ide today, to participate in a community service e...rm,s support for literacy with charitable giving. ...m,s long history of volunteerism. Instead of holid...f caring to brighten the holidays for some childre...
(Date:12/4/2009)..., Mo., Dec. 4 The large, two-day f...ation of Free Clinics (NAFC) in Kansas City on Wed...lso for anyone who is uninsured and has not seen a...linic will receive preventive primary care. ,,...e free clinic events this fall in Houston, New Orl...
(Date:12/4/2009)...isk for some pediatric cancers, particularly Ewing..., according to a new study published online Decemb...ute . , This study was undertaken because there ...ars and up to 20 years) for pediatric cancer patie...ac Cancer Center and Blood Disorders Service, Chil...
(Date:12/4/2009)...s it that men can be bastards and women must wear ...n. The answer, according to an article in the Jou...facial expressions. , In two studies, researcher...f faces. In the first study, androgynous faces wit...ns) were more likely to be identified as male, and...
(Date:12/4/2009)...4 Substantial progress has been ma...ity,s ability to diagnose and treat epilepsy and i...anagement has not reached most of the 50 million p...ly three million people in the United States who h...achter, M.D., president of the American Epilepsy S...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Are angry women more like men? 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...e the availability of life-saving antiretroviral t...ficiency virus) continue to die and suffer from co...is and initiation of treatment. A researcher at th...t their findings in the November issue of the jour...
...proved Patient Care, HUNTINGTON PARK, Calif., Nov...under of the United Farm Workers of,America, will ...pitals of,Huntington Park for a walkthrough to she...high quality patient care by raising,standards for...
...5th anniversary,celebration benefiting research an... Hospital, will be held at 6 p.m. Thursday, Nov. 8...This year,s celebration will honor Bloomfield resi...ce by the,Scintas, voted one of the top five group...
...pital, Fairview physicians have performed the firs...ecessive dystrophic epidermolysis bullosa (RDEB). ...s skin to the body, resulting in fragile skin that... and infection. The 18-month-old boy who was tran...
...ustralia and New Zealand, COPPELL, Texas, Nov. 2 ...g developer and provider of dietary,supplements an...ian,Convention at the Acer Arena in Sydney, Austra...d introducing the Australasian market to several n...
...dical Women,s,Association (AMWA) today voiced supp...creening and Detection Coverage Act of 2007, that ...advanced cervical cancer,screening techniques. The...ith a Pap test, as part of cervical,cancer screeni...
Other Medicine News:Health News:Testing delays cause severe AIDS complications, Einstein researchers find 2Health News:U of M performs first systemic therapy for fatal childhood disease 2Health News:Mannatech Hosts Australasian Convention 2Health News:Mannatech Hosts Australasian Convention 3Health News:American Medical Women's Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 2Health News:American Medical Women's Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 3
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: